Based on a number of prospective clinical trials, the latest iwCLL guidelines for the management of CLL recommend performing FISH analysis as well as analysis of TP53 gene in all patients with CLL, in both general practice and clinical trials. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.